Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes

JAMA Network Open

Volumn 1, Issue 8, 2018, Pages

  Goniewicz, Maciej L ^a   Smith, Danielle M ^a   Edwards, Kathryn C ^b   Blount, Benjamin C ^c   Caldwell, Kathleen L ^c   Feng, Jun ^c   Wang, Lanqing ^c   Christensen, Carol ^d   Ambrose, Bridget ^d   Borek, Nicolette ^d   Van Bemmel, Dana ^d   Konkel, Karen ^d   Erives, Gladys ^d   Stanton, Cassandra A ^b   Lambert, Elizabeth ^e   Kimmel, Heather L ^e   Hatsukami, Dorothy ^f   Hecht, Stephen S ^f   Niaura, Raymond S ^g   Travers, Mark ^a   Lawrence, Charles ^b   Hyland, Andrew J ^a   more..

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CENTER FOR TOBACCO PRODUCTS   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g American Legacy Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; METAL; NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; EXPOSURE; FEMALE; HUMAN; MALE; MIDDLE AGED; SMOKING; UNITED STATES; URINE; VAPING;

ADULT; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; METALS; MIDDLE AGED; NICOTINE; NITROSAMINES; POLYCYCLIC AROMATIC HYDROCARBONS; SMOKING; UNITED STATES; VAPING;

EID: 85061886606     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2018.5937     Document Type: Article

References (51)

1. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
2. Orr MS. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tob Control. 2014; 23 (suppl 2): ii18-ii22. doi: 10.1136/tobaccocontrol-2013-051474 24732158
3. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA. 2013; 310 (7): 685-686. doi: 10.1001/jama.2013.109501 23856948
4. Kasza KA, Ambrose BK, Conway KP, Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med. 2017; 376 (4): 342-353. doi: 10.1056/NEJMsa1607538 28121512
5. Coleman BN, Rostron B, Johnson SE, Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. Tob Control. 2017; 26 (e2): e117-e126. doi: 10.1136/tobaccocontrol-2016-053462 28624763
6. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014; 129 (19): 1972-1986. doi: 10.1161/CIRCULATIONAHA.114.007667 24821826
7. King BA, Patel R, Nguyen KH, Dube SR. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res. 2015; 17 (2): 219-227. doi: 10.1093/ntr/ntu191 25239961
8. D'Ruiz CD, Graff DW, Robinson E. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016; 16: 543. doi: 10.1186/s12889-016-3236-1 27401980
9. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017; 19 (2): 160-167. 27613896
10. McRobbie H, Phillips A, Goniewicz ML, Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila). 2015; 8 (9): 873-878. doi: 10.1158/1940-6207.CAPR-15-0058 26333731
11. O'Connell G, Graff DW, D'Ruiz CD. Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Toxicol Mech Methods. 2016; 26 (6): 443-454. 27401591
12. Shahab L, Goniewicz ML, Blount BC, Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017; 166 (6): 390-400. doi: 10.7326/M16-1107 28166548
13. Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY, Yang L, Hatsukami DK. Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop. Cancer Epidemiol Biomarkers Prev. 2017; 26 (3): 291-302. doi: 10.1158/1055-9965.EPI-16-0675 28151705
14. Hyland A, Ambrose BK, Conway KP, Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tob Control. 2017; 26 (4): 371-378. 27507901
15. National Addiction and HIV Data Archive Program (NAHDAP). Population Assessment of Tobacco and Health (PATH) Study Series. https://www.icpsr.umich.edu/icpsrweb/NAHDAP/series/606. Accessed August 14, 2018.
16. National Institute on Drug Abuse, and US Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Biomarker Restricted-Use Files (ICPSR36840). Ann Arbor, MI: Inter-university Consortium for Political and Social Research; 2017.
17. Aylward LL, Hays SM, Smolders R, Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev. 2014; 17 (1): 45-61. doi: 10.1080/10937404.2013.864250 24597909
18. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J. 1993; 54 (10): 615-627. doi: 10.1080/15298669391355134 8237794
19. Caudill SP, Schleicher RL, Pirkle JL. Multi-rule quality control for the age-related eye disease study. Stat Med. 2008; 27 (20): 4094-4106. doi: 10.1002/sim.3222 18344178
20. Alwis KU, Bailey TL, Patel D, Wang L, Blount BC. Measuring urinary N-acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-l-cysteine (IPMA3) as a potential biomarker of isoprene exposure. Anal Chim Acta. 2016; 941: 61-66. doi: 10.1016/j.aca.2016.08.023 27692379
21. Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta. 2012; 750: 152-160. doi: 10.1016/j.aca.2012.04.009 23062436
22. Bernert JT, Harmon TL, Sosnoff CS, McGuffey JE. Use of continine immunoassay test strips for preclassifying urine samples from smokers and nonsmokers prior to analysis by LC-MS-MS. J Anal Toxicol. 2005; 29 (8): 814-818. doi: 10.1093/jat/29.8.814 16374940
23. Caldwell KL, Hartel J, Jarrett J, Jones RL. Inductively coupled plasma mass spectrometry to measure multiple toxic elements in urine in NHANES 1999-2000. At Spectr. 2005; 26 (1): 1-7.
24. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol. 2009; 19 (1): 59-68. doi: 10.1038/jes.2008.32 18523458
25. Jarrett JM, Xiao G, Caldwell KL, Henahan D, Shakirova G, Jones RL. Eliminating molybdenum oxide interference in urine cadmium biomonitoring using ICP-DRC-MS. J Anal At Spectrom. 2008; 23 (7): 962. doi: 10.1039/b801927d
26. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the US population to secondhand smoke: 1988-2002. Environ Health Perspect. 2006; 114 (6): 853-858. doi: 10.1289/ehp.8850 16759984
27. Verdon CP, Caldwell KL, Fresquez MR, Jones RL. Determination of seven arsenic compounds in urine by HPLC-ICP-DRC-MS: a CDC population biomonitoring method. Anal Bioanal Chem. 2009; 393 (3): 939-947. doi: 10.1007/s00216-008-2537-3 19082583
28. Wang Y, Meng L, Pittman EN, Quantification of urinary mono-hydroxylated metabolites of polycyclic aromatic hydrocarbons by on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2017; 409 (4): 931-937. doi: 10.1007/s00216-016-9933-x 27796450
29. Wei B, Feng J, Rehmani IJ, A high-throughput robotic sample preparation system and HPLC-MS/MS for measuring urinary anatabine, anabasine, nicotine and major nicotine metabolites. Clin Chim Acta. 2014; 436: 290-297. doi: 10.1016/j.cca.2014.06.012 24968308
30. Xia B, Xia Y, Wong J, Quantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry. Biomed Chromatogr. 2014; 28 (3): 375-384. doi: 10.1002/bmc.3031 24127240
31. Batterman S, Chin JY, Jia C, Sources, concentrations, and risks of naphthalene in indoor and outdoor air. Indoor Air. 2012; 22 (4): 266-278. doi: 10.1111/j.1600-0668.2011.00760.x 22145682
32. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004; 83:81-83. 15285078
33. England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med. 2015; 49 (2): 286-293. doi: 10.1016/j.amepre.2015.01.015 25794473
34. Faroon O, Roney N, Taylor J, Ashizawa A, Lumpkin MH, Plewak DJ. Acrolein health effects. Toxicol Ind Health. 2008; 24 (7): 447-490. doi: 10.1177/0748233708094188 19028774
35. Freitas F, Brucker N, Durgante J, Urinary 1-hydroxypyrene is associated with oxidative stress and inflammatory biomarkers in acute myocardial infarction. Int J Environ Res Public Health. 2014; 11 (9): 9024-9037. doi: 10.3390/ijerph110909024 25257356
36. Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Fed Regist. 2012; 77 (64): 20034-20037.
37. Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009; 24 (1): 15-45. doi: 10.1515/REVEH.2009.24.1.15 19476290
38. Satarug S, Garrett SH, Sens MA, Sens DA. Cadmium, environmental exposure, and health outcomes. Environ Health Perspect. 2010; 118 (2): 182-190. doi: 10.1289/ehp.0901234 20123617
39. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
40. Vesper HW, Caudill SP, Osterloh JD, Meyers T, Scott D, Myers GL. Exposure of the US population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect. 2010; 118 (2): 278-283. doi: 10.1289/ehp.0901021 20123601
41. World Health Organization. Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Lyon, France: International Agency for Research on Cancer; 2007.
42. Henning RJ, Johnson GT, Coyle JP, Harbison RD. Acrolein can cause cardiovascular disease: a review. Cardiovasc Toxicol. 2017; 17 (3): 227-236. doi: 10.1007/s12012-016-9396-5 28084565
43. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990; 5 (1): 46-51. doi: 10.1080/1047322X.1990.10389587
44. Stata Statistical Software, release 14. College Station, TX: StataCorp LP; 2015.
45. Wagener TL, Floyd EL, Stepanov I, Have combustible cigarettes met their match? the nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control. 2017;26(e1):e23-e28. 27729564
46. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 2002; 23 (6): 907-922. doi: 10.1093/carcin/23.6.907 12082012
47. National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. https://www.ncbi.nlm.nih.gov/books/NBK507187/. Published 2018. Accessed August 14, 2018.
48. Alwis KU, deCastro BR, Morrow JC, Blount BC. Acrolein exposure in US tobacco smokers and non-tobacco users: NHANES 2005-2006. Environ Health Perspect. 2015; 123 (12): 1302-1308. doi: 10.1289/ehp.1409251 26024353
49. Saxena K, Liang Q, Muhammad-Kah R, Sarkar M. Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007-2012. Biomarkers. 2017; 22 (5): 403-412. doi: 10.1080/1354750X.2016.1201536 27321022
50. Aherrera A, Olmedo P, Grau-Perez M, The association of e-cigarette use with exposure to nickel and chromium: a preliminary study of non-invasive biomarkers. Environ Res. 2017; 159: 313-320. doi: 10.1016/j.envres.2017.08.014 28837903
51. Kosmider L, Sobczak A, Prokopowicz A, Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax. 2016; 71 (4): 376-377. doi: 10.1136/thoraxjnl-2015-207895 26822067